Mn Services Vermogensbeheer B.V. Acquires 1,000 Shares of Veeva Systems Inc. (NYSE:VEEV)

Mn Services Vermogensbeheer B.V. boosted its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 1.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 59,600 shares of the technology company’s stock after acquiring an additional 1,000 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Veeva Systems were worth $12,531,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Veeva Systems by 72.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after buying an additional 50 shares in the last quarter. Centricity Wealth Management LLC purchased a new stake in Veeva Systems during the fourth quarter valued at approximately $25,000. True Wealth Design LLC boosted its stake in Veeva Systems by 3,375.0% in the third quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after acquiring an additional 135 shares in the last quarter. Retirement Wealth Solutions LLC purchased a new position in Veeva Systems in the fourth quarter worth $31,000. Finally, Avion Wealth increased its position in shares of Veeva Systems by 635.0% during the fourth quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after purchasing an additional 127 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.

Insider Buying and Selling

In other Veeva Systems news, SVP Jonathan Faddis sold 1,694 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total value of $390,128.20. Following the sale, the senior vice president now directly owns 8,061 shares of the company’s stock, valued at approximately $1,856,448.30. This trade represents a 17.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 10.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

VEEV has been the subject of a number of recent analyst reports. Bank of America raised their price objective on Veeva Systems from $280.00 to $290.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Robert W. Baird raised their price target on Veeva Systems from $275.00 to $283.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Stephens initiated coverage on shares of Veeva Systems in a report on Friday, December 20th. They set an “overweight” rating and a $280.00 price objective on the stock. StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research report on Monday, February 17th. Finally, Barclays boosted their target price on shares of Veeva Systems from $260.00 to $275.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seventeen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Veeva Systems currently has a consensus rating of “Moderate Buy” and an average target price of $255.08.

Veeva Systems Price Performance

Shares of NYSE VEEV opened at $221.28 on Friday. The stock has a market capitalization of $35.93 billion, a price-to-earnings ratio of 54.64, a PEG ratio of 1.89 and a beta of 0.85. The firm’s 50 day simple moving average is $223.85 and its 200-day simple moving average is $218.48. Veeva Systems Inc. has a 12 month low of $170.25 and a 12 month high of $258.93.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.